Microcystin-LR exposure induces cartilage degeneration and dysregulates osteoarthritis-associated targets: an integrative computational and experimental study
- 1Department of Orthopedic Trauma and Hand Surgery, The First Affiliated Hospital of Guangxi Medical University
- 2Collaborative Innovation Centre of Regenerative Medicine and Medical Bioresource Development and Application Co-Constructed by the Province and Ministry, Guangxi Medical University
Abstract
Introduction: Microcystin‐LR (MC‐LR), a prevalent cyanotoxin in eutrophic freshwater, is becoming a more widespread environmental contaminant as global warming promotes cyanobacterial blooms, and its health effects may extend beyond its well-documented hepatotoxicity.
Methods: Here, we integrated network toxicology, machine learning, molecular dynamics simulation (MDS), and in vitro and in vivo experiments to investigate the role of MC‐LR in osteoarthritis (OA). A total of 368 predicted MC‐LR targets were intersected with OA‐related differentially expressed genes from five batch-corrected Gene Expression Omnibus (GEO) datasets.
Results: Weighted gene co-expression network analysis (WGCNA) identified a disease-correlated red module (r = 0.61, p = 2.3e–13), and least absolute shrinkage and selection operator (LASSO) regression narrowed the candidates to a six‐gene diagnostic signature (FAP, IGF1R, IGF1, MMP9, CRABP2, and ITGA4), with a combined area under the curve (AUC) of 0.910. CIBERSORT analysis indicated altered macrophage polarization and T‐cell redistribution within the osteoarthritic microenvironment. Molecular docking and 100-ns MDS showed that MC‐LR formed thermodynamically favorable and stable complexes with the five upregulated core targets, with FAP exhibiting the strongest binding affinity (–10.3 kcal/mol). In human chondrocytes, MC-LR exposure was cytotoxic (IC ₅₀ = 13.09 μM) and upregulated the mRNA levels of CRABP2, FAP, IGF1, ITGA4, and MMP9, consistent with the in silico predictions. Intra-articular injection of MC‐LR in mice induced dose-dependent knee cartilage degeneration, with matrix loss and elevated OARSI scores.
Discussion: Together, these findings associate MC‐LR exposure with cartilage degeneration under experimental conditions and implicate PI3K‐Akt signaling, focal adhesion, and extracellular matrix remodeling as candidate mechanisms, extending the recognized effects of cyanotoxins beyond the liver and highlighting chronic pollutant exposure as an underrecognized potential risk factor for degenerative joint disease.
Related
- Roflumilast mitigates cartilage degeneration in osteoarthritis by activating CFTR-mediated anti-apoptotic signaling.
- From cartilage degeneration to pain sensitization: a multi-tissue mitochondrial dysfunction network in osteoarthritis
- Bridging joint degeneration and systemic skeletal fragility: knee osteoarthritis as an independent risk factor for osteoporosis
- Tacrolimus attenuates BCL-2/BAX-mediated chondrocyte apoptosis and cartilage matrix degradation in experimental osteoarthritis
- Network Pharmacology of Natural Products from Computational Prediction to Experimental Validation
BibTeX
@article{tang2026microcystinlr,
title = {{Microcystin-LR exposure induces cartilage degeneration and dysregulates osteoarthritis-associated targets: an integrative computational and experimental study}},
author = {Zhifang Tang and Zuyong Feng and Zhiyu Liang and Shijie Liao and Xiaofei Ding},
journal = {Frontiers in Pharmacology},
year = {2026},
month = oct,
doi = {10.3389/fphar.2026.1910273},
url = {https://www.frontiersin.org/articles/10.3389/fphar.2026.1910273/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Microcystin-LR exposure induces cartilage degeneration and dysregulates osteoarthritis-associated targets: an integrative computational and experimental study
AU - Zhifang Tang
AU - Zuyong Feng
AU - Zhiyu Liang
AU - Shijie Liao
AU - Xiaofei Ding
PY - 2026
DA - 2026/10/26
JO - Frontiers in Pharmacology
DO - 10.3389/fphar.2026.1910273
UR - https://www.frontiersin.org/articles/10.3389/fphar.2026.1910273/full
AB - Introduction: Microcystin‐LR (MC‐LR), a prevalent cyanotoxin in eutrophic freshwater, is becoming a more widespread environmental contaminant as global warming promotes cyanobacterial blooms, and its health effects may extend beyond its well-documented hepatotoxicity. Methods: Here, we integrated network toxicology, machine learning, molecular dynamics simulation (MDS), and in vitro and in vivo experiments to investigate the role of MC‐LR in osteoarthritis (OA). A total of 368 predicted MC‐LR targets were intersected with OA‐related differentially expressed genes from five batch-corrected Gene Expression Omnibus (GEO) datasets. Results: Weighted gene co-expression network analysis (WGCNA) identified a disease-correlated red module (r = 0.61, p = 2.3e–13), and least absolute shrinkage and selection operator (LASSO) regression narrowed the candidates to a six‐gene diagnostic signature (FAP, IGF1R, IGF1, MMP9, CRABP2, and ITGA4), with a combined area under the curve (AUC) of 0.910. CIBERSORT analysis indicated altered macrophage polarization and T‐cell redistribution within the osteoarthritic microenvironment. Molecular docking and 100-ns MDS showed that MC‐LR formed thermodynamically favorable and stable complexes with the five upregulated core targets, with FAP exhibiting the strongest binding affinity (–10.3 kcal/mol). In human chondrocytes, MC-LR exposure was cytotoxic (IC ₅₀ = 13.09 μM) and upregulated the mRNA levels of CRABP2, FAP, IGF1, ITGA4, and MMP9, consistent with the in silico predictions. Intra-articular injection of MC‐LR in mice induced dose-dependent knee cartilage degeneration, with matrix loss and elevated OARSI scores. Discussion: Together, these findings associate MC‐LR exposure with cartilage degeneration under experimental conditions and implicate PI3K‐Akt signaling, focal adhesion, and extracellular matrix remodeling as candidate mechanisms, extending the recognized effects of cyanotoxins beyond the liver and highlighting chronic pollutant exposure as an underrecognized potential risk factor for degenerative joint disease.
SN - 1663-9812
ER -